The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Prevalence of Symptomatic Androgen Deficiency in Men
Abstract
Context: Despite recognition that androgen deficiency in men should be defined according to biochemical and clinical criteria, most prevalence estimates are based on low testosterone levels alone. Objective: The objective of this study was to examine the association between symptoms of androgen deficiency and low total and calculated free testosterone levels and estimate the prevalence of symptomatic androgen deficiency in men. Design: This study was a population-based, observational survey. Participants: A total of 1475 Black, Hispanic, and white men, between the ages of 30–79 yr, with complete data on testosterone, SHBG, and symptoms of androgen deficiency, and who are not taking medications that impact sex steroid levels were randomly selected from the Boston Area Community Health Survey. Outcome: Outcomes were measured as symptomatic androgen deficiency, defined as low total (<300 ng/dl) and free (<5 ng/dl) testosterone plus presence of low libido, erectile dysfunction, osteoporosis or fracture, or two or more of following symptoms: sleep disturbance, depressed mood, lethargy, or diminished physical performance. Results: Mean age of the sample was 47.3 ± 12.5 yr. Approximately 24% of subjects had total testosterone less than 300 ng/dl, and 11% of subjects had free testosterone less than 5 ng/dl. Prevalence of symptoms were as follows: low libido (12%), erectile dysfunction (16%), osteoporosis/fracture (1%), and two or more of the nonspecific symptoms (20%). Low testosterone levels were associated with symptoms, but many men with low testosterone levels were asymptomatic (e.g. in men 50+ yr, 47.6%). Crude prevalence of symptomatic androgen deficiency was 5.6% (95% confidence interval: 3.6%, 8.6%), and was not significantly related to race and ethnic group. Prevalence was low in men less than 70 yr (3.1–7.0%) and increased markedly with age to 18.4% among 70 yr olds. Projection of these estimates to the year 2025 suggests that there will be as many as 6.5 million American men ages 30–79 yr with symptomatic androgen deficiency, an increase of 38% from 2000 population estimates. Conclusions: Prevalence of symptomatic androgen deficiency in men 30 and 79 yr of age is 5.6% and increases substantially with age. The aging of the U.S. male population will cause a large increase in the burden of symptomatic androgen deficiency. Future work should address the clinical significance of low testosterone levels in asymptomatic men.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prevalence of symptomatic hypogonadism remains poorly defined, with estimates ranging from 2.1–17% in population-based surveys of men aged 30–87 years depending upon criterion utilized.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“However, many of these studies are hindered by heterogeneity in the definition for low fT (50–65 pg/ml [173.4–225.4 pmol/L]), with increases in the threshold for low fT resulting in higher sensitivity and reduced specificity when compared to TT.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“Other studies have also demonstrated increased associations between fT and other comorbid conditions, including depression and hypogonadal symptoms.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“Free T is also better indicator in young males as compared to elderly men, suggesting that the age-associated increase in SHBG may further reduce the specificity of fT.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“The authors noted that increasing the lower fT threshold (50–60, or 60–70pg/ml [173.4–208 and 208–242.7 pmol/L]) resulted in reduced specificity for symptoms such as low libido (28.1%, 23.9%, and 19.8% for 50, 60, and 70pg/ml [242.7 pmol/L], respectively).”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“The community prevalence estimates of potentially functional hypogonadism in middle-aged and older men (also referred to as late-onset, age-related, or adult-onset hypogonadism) vary from 2.1% to 12.3% (8–10)”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [9]
In the citing paper
“In other observational studies of middle-aged and older men, symptoms and low testosterone also seldomly occurred together (Supplemental Fig. 1) (8–10).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [9]
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
Brown, R. A., Hastie, T. J., & Tibshirani, R. J. (1991) · Biometrics · doi:10.2307/2532174 · Cited by 8,263
Koyak, R. A., Hastie, T. J., & Tibshirani, R. J. (1991) · Journal of the American Statistical Association · doi:10.2307/2290538 · Cited by 7,717
Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997) · Urology · doi:10.1016/s0090-4295(97)00238-0 · Cited by 5,849
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Self-citationSödergard, R., Bäckström, T., Shanbhag, V., & Carstensen, H. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90038-3 · Cited by 1,080
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 722
Shores, M. M., Arnold, A. M., Biggs, M. L., Longstreth, W. T., Smith, N. L., Kizer, J. R., Cappola, A. R., Hirsch, C. H., Marck, B. T., & Matsumoto, A. M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12452 · Cited by 71
Chung, J., Chen, H.-W., Midzak, A. S., Burnett, A. L. “., Papadopoulos, V., & Zirkin, B. R. (2013) · Endocrinology · doi:10.1210/en.2012-2226 · Cited by 73
Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer
Pastuszak, A. W., Khanna, A., Badhiwala, N. G., Morgentaler, A., Hult, M., Conners, W. P., Sarosdy, M. F., Yang, C., Carrión, R., Lipshultz, L. I., et al. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.05.084 · Cited by 68
Ross, A., & Bhasin, S. (2016) · Urologic Clinics of North America · doi:10.1016/j.ucl.2016.01.002 · Cited by 69
Total testosterone quantitative measurement in serum by LC-MS/MS
Wang, Y., Gay, G. D., Botelho, J. C., Caudill, S. P., & Vesper, H. W. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.06.009 · Cited by 67
Osteoporosis in Klinefelter's syndrome
Ferlin, A., Schipilliti, M., Mambro, A. D., Vinanzi, C., & Foresta, C. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq026 · Cited by 71
Serum testosterone levels in male hypogonadism: Why and when to check-A review
Livingston, M. A., Kalansooriya, A., Hartland, A. J., Ramachandran, S., & Heald, A. H. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.12995 · Cited by 66
Critical evaluation of different available guidelines for late‐onset hypogonadism
Giagulli, V., Castellana, M., Lisco, G., & Triggiani, V. (2020) · Andrology · doi:10.1111/andr.12850 · Cited by 54
Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men
Lunenfeld, B., Mskhalaya, G. J., Zitzmann, M., Corona, G., Arver, S., Kalinchenko, S. Y., Tishova, Y. A., & Morgentaler, A. (2021) · The Aging Male · doi:10.1080/13685538.2021.1962840 · Cited by 65
Magnussen, L. V., Glintborg, D., Hermann, A. P., HOUGAARD, D. M., Højlund, K., & Andersen, M. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12701 · Cited by 64
Hackbarth, J. S., Hoyne, J. B., Grebe, S. K. G., & Singh, R. (2010) · Steroids · doi:10.1016/j.steroids.2010.08.008 · Cited by 62
Pastuszak, A. W., Moon, Y. M., Scovell, J., Badal, J., Lamb, D. J., Link, R. E., & Lipshultz, L. I. (2017) · Urology · doi:10.1016/j.urology.2016.11.033 · Cited by 62
Chiang, J. M., Kaysen, G. A., Segal, M. R., Chertow, G. M., Delgado, C., & Johansen, K. L. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy252 · Cited by 62
Vitamin D and Testosterone in Healthy Men: A Randomized Controlled Trial
Lerchbaum, E., Pilz, S., Trummer, C., Schwetz, V., Pachernegg, O., Heijboer, A. C., & Obermayer-Pietsch, B. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01428 · Cited by 60
Anderson, R. A., Clatot, F., Demeestere, I., Lambertini, M., Morgan, A. A., Nelson, S. M., Peccatori, F. A., & Cameron, D. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.11.032 · Cited by 61
Total testosterone levels are correlated to metabolic syndrome components
Blaya, R., Thomaz, L. D. G. R., Guilhermano, F., Paludo, A. D. O., Rhoden, L., Halmenschlager, G., & Rhoden, E. L. (2016) · The Aging Male · doi:10.3109/13685538.2016.1154523 · Cited by 60
Late-Life Onset Hypogonadism: A Review
Bassil, N., & Morley, J. E. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2010.02.003 · Cited by 59
Traish, A. M., & Zitzmann, M. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-015-9323-2 · Cited by 57
Predicting low testosterone in aging men: a systematic review
Millar, A. C., Lau, A. N. C., TOMLINSON, G. A., Kraguljac, A. P., Simel, D. L., Detsky, A. S., & Lipscombe, L. L. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.150262 · Cited by 58
Clomiphene citrate for men with hypogonadism: a systematic review and meta‐analysis
Huijben, M., Lock, M. T. W. T., de Kemp, V. F., de Kort, L. M. O., & van Breda, J. (2021) · Andrology · doi:10.1111/andr.13146 · Cited by 59
Anawalt, B. D., Hotaling, J. M., Walsh, T. J., & Matsumoto, A. M. (2012) · Journal of Urology · doi:10.1016/j.juro.2011.11.095 · Cited by 55
Aging and androgens: Physiology and clinical implications
Anawalt, B. D., & Matsumoto, A. M. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09765-2 · Cited by 55
Testosterone deficiency in adults and corresponding treatment patterns across the globe
Anaissie, J. E., DeLay, K. J., Wang, W., Hatzichristodoulou, G., & Hellstrom, W. J. G. (2017) · Translational Andrology and Urology · doi:10.21037/tau.2016.11.16 · Cited by 57
Westley, C. J., AMDUR, R. L., & Irwig, M. S. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12937 · Cited by 54
Transdermal testosterone replacement therapy in men
Koch, C. A., Ullah, M. I., & Riche, D. M. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s43475 · Cited by 54
Rohrmann, S., Platz, E. A., Selvin, E., Shiels, M. S., Joshu, C. E., Menke, A., Feinleib, M., Basaria, S. S., Rifai, N., Dobs, A. S., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04043.x · Cited by 54
Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Basaria, S. S., & Lakshman, K. M. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s4466 · Cited by 53
Do low testosterone levels contribute to ill-health during male ageing?
Yeap, B. B., de Araújo, A. B., & Wittert, G. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.725461 · Cited by 53
Botto, H., Neuzillet, Y., Lebrét, T., Camparo, P., Molinié, V., & Raynaud, J. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.05.082 · Cited by 52
Amiaz, R., Pope, H. G., Mahne, T., Kelly, J. F., Brennan, B. P., Kanayama, G., Weiser, M., Hudson, J. I., & Seidman, S. N. (2011) · Journal of Sex & Marital Therapy · doi:10.1080/0092623x.2011.582425 · Cited by 52
Dinsmore, W. W., & Wyllie, M. G. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10837.x · Cited by 51
Kaplan, S. A., Lee, J. Y., O’Neill, E. A., Meehan, A. G., & Kusek, J. W. (2013) · The Aging Male · doi:10.3109/13685538.2013.844786 · Cited by 51
Marketing and Testosterone Treatment in the USA: A Systematic Review
Bandari, J., Ayyash, O. M., Emery, S., Wessel, C. B., & Davies, B. J. (2017) · European Urology Focus · doi:10.1016/j.euf.2017.10.016 · Cited by 51
Chung, J., Brown, S., Chen, H., Liu, J., Papadopoulos, V., & Zirkin, B. R. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz174 · Cited by 51
The Emerging Link Between Hypogonadism and Metabolic Syndrome
Guay, A. T. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.006015 · Cited by 50
Bassil, N. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.03.001 · Cited by 50
Predicting Biochemical Response to Clomiphene Citrate in Men with Hypogonadism
Mazzola, C. R., Katz, D. J., Loghmanieh, N., Nelson, C. J., & Mulhall, J. P. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12592 · Cited by 50
Traish, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_22 · Cited by 50
Atlantis, E. E., Martin, S., Haren, M. T., O’Loughlin, P. D., Taylor, A. W., Anand‐Ivell, R., Ivell, R., Wittert, G., & Study, M. O. T. F. A. M. A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03463.x · Cited by 49
Frost, M., Wraae, K., Nielsen, T. L., HOUGAARD, D. M., Brixen, K., Hagen, C., & Andersen, M. (2012) · Clinical Endocrinology · doi:10.1111/cen.12042 · Cited by 48
Impaired emotional state, quality of life and cognitive functions in young hypogonadal men
Lašaitė, L., Čeponis, J., Preikša, R. T., & Žilaitienė, B. (2013) · Andrologia · doi:10.1111/and.12199 · Cited by 47
An update on male hypogonadism therapy
Surampudi, P. N., Swerdloff, R. S., & Wang, C. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.913022 · Cited by 46
Konaka, H., Sugimoto, K., Orikasa, H., Iwamoto, T., Takamura, T., Takeda, Y., Shigehara, K., Iijima, M., Koh, E., Namiki, M., et al. (2015) · Asian Journal of Andrology · doi:10.4103/1008-682x.148720 · Cited by 45
Pexman-Fieth, C., Behre, H. M., Morales, Á., Kan‐Dobrosky, N., & Miller, M. G. (2013) · The Aging Male · doi:10.3109/13685538.2013.858113 · Cited by 45
Partial Androgen Deficiency, Depression, and Testosterone Supplementation in Aging Men
Amore, M., Innamorati, M., Costi, S., Sher, L., Girardi, P., & Pompili, M. (2012) · International Journal of Endocrinology · doi:10.1155/2012/280724 · Cited by 46
Chueh, K., Huang, S., Lee, Y., Wang, C., Yeh, H., Li, W., Wu, W., Tsai, Y., Tsai, C., Juan, H., et al. (2012) · Journal of Andrology · doi:10.2164/jandrol.111.015628 · Cited by 45
Schneider, H. J., Sievers, C., Klotsche, J., Böhler, S., Pittrow, D. B., Lehnert, H., Wïttchen, H., & Stalla, G. K. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03370.x · Cited by 45
Epidemiology of Male Hypogonadism
Thirumalai, A., & Anawalt, B. D. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.11.016 · Cited by 44
Pharmacokinetic Evaluation and Dosing of Subcutaneous Testosterone Pellets
Pastuszak, A. W., Mittakanti, H. R., Liu, J. S., Gomez, L., Lipshultz, L. I., & Khera, M. (2012) · Journal of Andrology · doi:10.2164/jandrol.111.016295 · Cited by 44
George, A., & Henkel, R. (2014) · Andrologia · doi:10.1111/and.12214 · Cited by 44
Effects of obstructive sleep apnea and its treatment over the erectile function: a systematic review
Campos‐Juanatey, F., Fernández-Barriales, M., González, M., & Portillo-Martín, J. A. (2015) · Asian Journal of Andrology · doi:10.4103/1008-682x.170440 · Cited by 44
Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?
López, D. S., Advani, S., Tsilidis, K. K., Wang, R., & Canfield, S. E. (2017) · Translational Andrology and Urology · doi:10.21037/tau.2017.05.35 · Cited by 44
Al‐Sharefi, A., & Quinton, R. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.760 · Cited by 44
Kaminetsky, J. C., Jaffe, J. S., & Swerdloff, R. S. (2015) · Sexual Medicine · doi:10.1002/sm2.80 · Cited by 43
Ahern, T., Święcicka, A., Eendebak, R. J. A. H., Carter, E. L., Finn, J. D., Pye, S. R., O’Neill, T. W., Antonio, L., Keevil, B. G., Bártfai, G., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13152 · Cited by 43
Diagnosis and management of testosterone deficiency
Coward, R. M., McBride, J., & Carson, C. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.143317 · Cited by 45
Temporal trends in testosterone levels and treatment in older men
Travison, T. G., de Araújo, A. B., Hall, S. A., & McKinlay, J. B. (2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32832b6348 · Cited by 43
Self-citationDudek, P., Kozakowski, J., & Zgliczyński, W. (2017) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2017.68595 · Cited by 43
Chen, Z., Zhang, Y., Lu, C., Zeng, H., Schumann, M., & Cheng, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00843 · Cited by 44
The pathophysiology of osteoporotic hip fracture
Metcalfe, D. (2020) · McGill Journal of Medicine · doi:10.26443/mjm.v11i1.410 · Cited by 42
Kathrins, M. N., Doersch, K., Nimeh, T., Canto, A., Niederberger, C., & Seftel, A. D. (2015) · Urology · doi:10.1016/j.urology.2015.11.006 · Cited by 41
Ho, C.-H., Yu, H.-J., Wang, C.-Y., Jaw, F.-S., Hsieh, J.-T., Liao, W.-C., Pu, Y.-S., & Liu, S.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074173 · Cited by 40
Testosterone, thrombophilia, thrombosis
Freedman, J., Glueck, C. J., Prince, M., Riaz, R., & Wang, P. (2015) · Translational research · doi:10.1016/j.trsl.2014.12.003 · Cited by 41
High risk of hypogonadism in young male cancer survivors
Isaksson, S., Bogefors, K., Ståhl, O., Eberhard, J., Giwercman, Y. L., Leijonhufvud, I., Link, K., Øra, I., Romerius, P., Bobjer, J., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13534 · Cited by 40
How to help the aging male? Current approaches to hypogonadism in primary care
Lunenfeld, B., Arver, S., Moncada, I., Rees, A., & Schulte, H. M. (2012) · The Aging Male · doi:10.3109/13685538.2012.729110 · Cited by 40
Treatment of Symptomatic Androgen Deficiency Results From the Boston Area Community Health Survey
Hall, S. A. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.10.1070 · Cited by 39
Walsh, T. J., Shores, M. M., Krakauer, C. A., Forsberg, C. W., Fox, A., Moore, K. P., Korpak, A. M., Heckbert, S. R., Zeliadt, S. B., Kinsey, C. E., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199194 · Cited by 39
Hypogonadism in aged hospitalized male patients: prevalence and clinical outcome
Iglesias, P., Prado, F., Macías, M. C., Guerrero, M. T., Muñoz, A., Ridruejo, E., Tajada, P., García-Arévalo, C., & Díez, J. J. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0009-x · Cited by 38
Systematic Literature Review of the Epidemiology of Nongenetic Forms of Hypogonadism in Adult Males
Zarotsky, V., Huang, M., Carman, W. J., Morgentaler, A., Singhal, P. K., Coffin, D., & Jones, T. H. (2014) · Journal of Hormones · doi:10.1155/2014/190347 · Cited by 38
Lašaitė, L., Čeponis, J., Preikša, R. T., & Žilaitienė, B. (2016) · Andrologia · doi:10.1111/and.12633 · Cited by 37
The Effect of Androgen-replacement Therapy on Prostate Growth: A Systematic Review and Meta-analysis
Cui, Y., & Zhang, Y. (2013) · European Urology · doi:10.1016/j.eururo.2013.03.042 · Cited by 37
Patients with testosterone deficit syndrome and depression.
Khera, M. (2013) · PubMed · Cited by 36
The CATCH checklist to investigate adult‐onset hypogonadism
Defeudis, G., Mazzilli, R., Gianfrilli, D., Lenzi, A., & Isidori, A. M. (2018) · Andrology · doi:10.1111/andr.12506 · Cited by 37
Testosterone, myocardial function, and mortality
Bianchi, V. E. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9721-0 · Cited by 37
Vartolomei, M. D., Kimura, S., Vartolomei, L., & Shariat, S. F. (2018) · European Urology Focus · doi:10.1016/j.euf.2018.07.006 · Cited by 37
Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses
Guay, A., Seftel, A. D., & Traish, A. M. (2009) · International Journal of Impotence Research · doi:10.1038/ijir.2009.46 · Cited by 37
Testosterone Replacement Therapy in Hypogonadal Men: Assessing Benefits, Risks, and Best Practices
Miner, M. M., Canty, D. J., & Shabsigh, R. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.09.1914 · Cited by 35
Identification of late-onset hypogonadism in middle-aged and elderly men from a community of China
Sun, Y., Liu, Z., Zhou, R., Lü, X., Zeng, Q., Wang, H., & Li, Z. (2015) · Asian Journal of Andrology · doi:10.4103/1008-682x.160883 · Cited by 35
Zaid, M. I. A., Gathirua‐Mwangi, W. G., Fung, C., Monahan, P. O., El-Charif, O., Williams, A. M., Feldman, D. R., Hamilton, R. J., Vaughn, D. J., Beard, C. J., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.7046 · Cited by 35
Pühse, G., Secker, A., Kemper, S., Hertle, L., & Kliesch, S. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01123.x · Cited by 35
The Long and Tortuous History of the Discovery of Testosterone and Its Clinical Application
Morales, Á. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12081 · Cited by 35
The Effect of Sex Hormone Deficiency on the Incidence of Rotator Cuff Repair
Smith, K. M., Hotaling, J. M., Presson, A. P., Zhang, C., Horns, J. J., Cannon‐Albright, L., Teerlink, C. C., Tashjian, R. Z., & Chalmers, P. N. (2022) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.21.00103 · Cited by 34
Desai, A., Yassin, M., Cayetano-Alcaráz, A. A., Tharakan, T., Jayasena, C. N., & Minhas, S. (2022) · Therapeutic Advances in Urology · doi:10.1177/17562872221105017 · Cited by 34
The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
Shin, Y. S., & Park, J. K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020209 · Cited by 34
Gao, T., Lin, M., Shao, B., Zhou, Q., Wang, Y., Chen, X., Zhao, D., Dai, X., Shen, C., Cheng, H., et al. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1779471 · Cited by 34
Tong, S. F., Ng, C. J., Lee, B.-C., Lee, V. K. M., Khoo, E. M., Lee, E.-G., & Tan, H. M. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2011.178 · Cited by 34
Testosterone Is Associated with Erectile Dysfunction: A Cross-Sectional Study in Chinese Men
Liao, M., Huang, X., Gao, Y., Tan, A., Lu, Z., Wu, C., Zhang, Y., Yang, X., Zhang, H., Qin, X. Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039234 · Cited by 34
Roles of Testosterone Replacement in Cardiac Ischemia–Reperfusion Injury
Pongkan, W., Chattipakorn, S. C., & Chattipakorn, N. (2015) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248415587977 · Cited by 34
Time for international action on treating testosterone deficiency syndrome
Carruthers, M. E. (2009) · The Aging Male · doi:10.1080/13685530802699067 · Cited by 33
Male hormones and men's quality of life
Khera, M. (2016) · Current Opinion in Urology · doi:10.1097/mou.0000000000000256 · Cited by 33
Déficit de testosterona, síndrome metabólico y diabetes mellitus
Fernández-Miró, M., Chillarón, J. J., & Pedro‐Botet, J. (2015) · Medicina Clínica · doi:10.1016/j.medcli.2015.06.020 · Cited by 33
Immune-Mediated Diseases from the Point of View of Psychoneuroimmunoendocrinology
Ortega, M. A., Montero, C. G., Fraile‐Μartinez, O., Álvarez-Mon, M. Á., Gomez-Lahoz, A. M., Lahera, G., Monserrat, J., Rodríguez–Jiménez, R., Quintero, J., & Álvarez‐Mon, M. (2022) · Biology · doi:10.3390/biology11070973 · Cited by 33
Review of health risks of low testosterone and testosterone administration
Jia, H. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i4.338 · Cited by 33
Xu, W., Niu, T., Xu, B., Navarro, G., Schipma, M. J., & Mauvais‐Jarvis, F. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.03.002 · Cited by 33
Testosterone administration in older men
Matsumoto, A. M. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.02.011 · Cited by 32
Detecting people at high risk of type 2 diabetes- How do we find them and who should be treated?
Kong, A. P. S., Luk, A. O. Y., & Chan, J. C. N. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.06.003 · Cited by 36
Testosterone Imposters: An Analysis of Popular Online Testosterone Boosting Supplements
Balasubramanian, A., Thirumavalavan, N., Srivatsav, A., Yu, J., Lipshultz, L. I., & Pastuszak, A. W. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.12.008 · Cited by 32
Biochemical endocrinology of the hypogonadal male
Belchetz, P. E., Barth, J. H., & Kaufman, J. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.010150 · Cited by 32
Enclomiphene citrate for the treatment of secondary male hypogonadism
Rodríguez, K. M. G., Pastuszak, A. W., & Lipshultz, L. I. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1204294 · Cited by 32
Novel Therapy for Male Hypogonadism
Carrasquillo, R., Chu, K., & Ramasamy, R. (2018) · Current Urology Reports · doi:10.1007/s11934-018-0816-x · Cited by 31
Metadata
- Authors
- Araujo, A. B., Esche, G. R., Kupelian, V., O’Donnell, A. B., Travison, T. G., Williams, R. E., Clark, R. V., & McKinlay, J. B.
- Affiliations
- New England Research Institutes, Inc. (A.B.A., G.R.E., V.K., A.B.O., T.G.T., J.B.M.), Watertown, Massachusetts 02472
- New England Research Institutes (US)
- GlaxoSmithKline (United States) (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-11-01
- Volume
- 92
- Issue
- 11
- Pages
- 4241-4247
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2135798327
- Cited by
- 720
- References
- 45
- Citations by year
- 2026: 16 · 2025: 32 · 2024: 23 · 2023: 31 · 2022: 46 · 2021: 30 · 2020: 40 · 2019: 29 · 2018: 28 · 2017: 46 · 2016: 58 · 2015: 49 · 2014: 57 · 2013: 48 · 2012: 45
- FWCI
- 25.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG020727)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK56842)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- androgen deficiency, free testosterone, prevalence, men, low libido, erectile dysfunction, osteoporosis, sex hormone-binding globulin, age-related decline, racial and ethnic differences, sex steroid levels, sleep disorders, depressive mood, physical performance, men's health, older men
- MeSH terms
- Adult, Aged, Androgens, Boston, Data Interpretation, Statistical, Endocrine System Diseases, Ethnicity, Humans, Male, Middle Aged, Gonadal Steroid Hormones, Testosterone, Cluster Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
